心力衰竭相关心源性休克的管理:国际RAND适宜性小组
该研究采用改良RAND/加州大学洛杉矶分校适宜性方法,由16名国际多学科专家对34条关于心力衰竭相关心源性休克(HF-CS)管理的陈述进行匿名评分(1-3不适宜,4-6不确定,7-9适宜)。结果显示20条评为适宜、14条评为不适宜,在HF-CS初始评估与管理、升级至临时机械循环支持(tMCS)、以及从tMCS撤机三个领域均存在不确定性。仅在讨论胸部超声在HF-CS即刻管理中的效用时,专家间出现显著分歧(分歧指数超过1)。作者结论认为,HF-CS人群亟需大规模前瞻性注册研究和临床试验,以可靠指导临床实践和未来学会指南的制定。
要点
- 16名国际专家对34条HF-CS管理陈述评分:20条适宜、14条不适宜。
- HF-CS初始评估与管理、升级至tMCS、从tMCS撤机三个领域均存在不确定性。
- 仅在胸部超声用于HF-CS即刻管理的效用上,专家分歧指数超过1,出现显著分歧。
- 目前尚无专门针对HF-CS的随机对照试验可靠指导临床实践或指南。
- 作者认为亟需大规模前瞻性注册研究和临床试验来指导HF-CS实践和指南制定。
适用人群与场景
- 因急性失代偿性慢性心力衰竭导致心源性休克(HF-CS)的危重症患者,尤其关注急性失代偿性慢性心衰所致HF-CS。
研究设计与关键结果
- 研究类型为改良RAND/加州大学洛杉矶分校适宜性方法专家小组共识,16名国际多学科专家参与,对34条HF-CS管理陈述进行匿名评分(1-3不适宜,4-6不确定,7-9适宜)。
- 34条陈述中,20条评为适宜,14条评为不适宜。
- HF-CS初始评估与管理、升级至临时机械循环支持(tMCS)、从tMCS撤机三个领域均存在不确定性。
- 仅在讨论胸部超声在HF-CS即刻管理中的效用时,专家间出现显著分歧(分歧指数超过1)。
证据类型、等级与局限
- 证据类型:国际多学科专家小组采用改良RAND/加州大学洛杉矶分校适宜性方法形成的共识。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,HF-CS人群亟需大规模前瞻性注册研究和临床试验,以可靠指导临床实践和未来学会HF-CS指南的制定。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Observational data suggest that the subset of patients with heart failure related CS (HF-CS) now predominate critical care admissions for CS. There are no dedicated HF-CS randomised control trials completed to date which reliably inform clinical practice or clinical guidelines. We sought to identify aspects of HF-CS care where both consensus and uncertainty may exist to guide clinical practice and future clinical trial design, with a specific focus on HF-CS due to acute decompensated chronic HF.
METHODS: A 16-person multi-disciplinary panel comprising of international experts was assembled. A modified RAND/University of California, Los Angeles, appropriateness methodology was used. A survey comprising of 34 statements was completed. Participants anonymously rated the appropriateness of each statement on a scale of 1 to 9 (1-3 as inappropriate, 4-6 as uncertain and as 7-9 appropriate).
RESULTS: Of the 34 statements, 20 were rated as appropriate and 14 were rated as inappropriate. Uncertainty existed across all three domains: the initial assessment and management of HF-CS; escalation to temporary Mechanical Circulatory Support (tMCS); and weaning from tMCS in HF-CS. Significant disagreement between experts (deemed present when the disagreement index exceeded 1) was only identified when deliberating the utility of thoracic ultrasound in the immediate management of HF-CS.
CONCLUSION: This study has highlighted several areas of practice where large-scale prospective registries and clinical trials in the HF-CS population are urgently needed to reliably inform clinical practice and the synthesis of future societal HF-CS guidelines.
参考来源
- Williams S, Kalakoutas A, Olusanya S, et al. The management of heart failure cardiogenic shock: an international RAND appropriateness panel. Crit Care. 2024. PMID: 38566212. doi:10.1186/s13054-024-04884-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。